Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of diabetes worldwide
3.2.1.2 Technological advancements in developed countries
3.2.1.3 Government initiatives for increasing awareness among people
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced devices and accessories in developing countries
3.2.2.2 Lack of reimbursement and stringent regulations for SMBG devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Self-monitoring blood glucose meters
5.3 Consumables
5.3.1 Testing strips
5.3.2 Lancets
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Type 1 diabetes
6.3 Type 2 diabetes
6.4 Gestational diabetes
Chapter 7 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgery centers
7.4 Diagnostic centers
7.5 Home care
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AgaMatrix
9.3 All Medicus Co., Ltd.
9.4 Arkray, Inc.
9.5 Ascensia Diabetes Care Holdings AG
9.6 B. Braun Melsungen AG
9.7 Bionime Corporation
9.8 DarioHealth Corp.
9.9 Dexcom, Inc.
9.10 Essenlife Bioscience, Inc.
9.11 F. Hoffmann-La Roche Ltd.
9.12 LifeScan Inc.
9.13 Medtronic plc
9.14 Nova Biomedical, Inc.
9.15 Sinocare Inc.
